Pages that link to "Q34322219"

The following pages link to Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection (Q34322219):

Displaying 30 items.

• Metagenomics: A New Way to Illustrate the Crosstalk between Infectious Diseases and Host Microbiome (Q26779142) (← links)
• Gut Microbiota in HIV Infection: Implication for Disease Progression and Management (Q27014742) (← links)
• Probiotics in Human Immunodeficiency Virus Infection: A Systematic Review and Evidence Synthesis of Benefits and Risks (Q28069649) (← links)
• Developments in HIV-1 immunotherapy and therapeutic vaccination. (Q30364312) (← links)
• HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation (Q30839904) (← links)
• Mucosal immunity in human and simian immunodeficiency lentivirus infections (Q34131265) (← links)
• Loss and dysregulation of Th17 cells during HIV infection (Q34350569) (← links)
• HIV-associated chronic immune activation (Q34653277) (← links)
• Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286. (Q35102590) (← links)
• Dysbiotic bacteria translocate in progressive SIV infection. (Q35542433) (← links)
• Longitudinal Survey of Microbiota in Hospitalized Preterm Very-Low-Birth-Weight Infants (Q35731183) (← links)
• Enhancement of Microbiota in Healthy Macaques Results in Beneficial Modulation of Mucosal and Systemic Immune Function (Q35908830) (← links)
• Microbiome alterations in HIV infection a review (Q35946623) (← links)
• CONSORT 2010 statement: extension to randomised pilot and feasibility trials (Q36173563) (← links)
• Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques. (Q36580442) (← links)
• Nutrition of the critically ill — a 21st-century perspective. (Q36607663) (← links)
• Serious Non-AIDS events: Immunopathogenesis and interventional strategies (Q37418140) (← links)
• Nutrition of the critically ill - emphasis on liver and pancreas (Q37584566) (← links)
• A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects (Q37595511) (← links)
• Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing (Q38177684) (← links)
• Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection (Q38749963) (← links)
• The gut microbiome and HIV-1 pathogenesis: a two-way street (Q38984137) (← links)
• Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients (Q40225216) (← links)
• The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects (Q40400842) (← links)
• The administration of probiotics and synbiotics in immune compromised adults: is it safe? (Q41705850) (← links)
• Effect of Probiotic Supplementation on CD4 Cell Count in HIV-Infected Patients: A Systematic Review and Meta-analysis (Q47571783) (← links)
• CONSORT 2010 statement: extension to randomised pilot and feasibility trials (Q53472579) (← links)
• Sex Differences in HIV Infection: Mystique Versus Machismo (Q56996082) (← links)
• HIV, Sexual Orientation, and Gut Microbiome Interactions (Q89587096) (← links)
• Effect of Lactobacillus plantarum IS-10506 on blood lipopolysaccharide level and immune response in HIV-infected children (Q92156333) (← links)